Inhibitory Effects of Tricyclic Antidepressants on Human Liver Microsomal Morphine Glucuronidation: Application of IVIVE to Predict Potential Drug-Drug Interactions in Humans
CONCLUSION: The results suggest that the likelihood of potential clinical DDIs arising from tricyclic antidepressant inhibition on morphine glucuronidation is low.PMID:38270153 | DOI:10.2174/0113892002270594231212090958 (Source: Current Drug Metabolism)
Source: Current Drug Metabolism - January 25, 2024 Category: Drugs & Pharmacology Authors: Verawan Uchaipichat Source Type: research

Inhibitory Effects of Tricyclic Antidepressants on Human Liver Microsomal Morphine Glucuronidation: Application of IVIVE to Predict Potential Drug-Drug Interactions in Humans
CONCLUSION: The results suggest that the likelihood of potential clinical DDIs arising from tricyclic antidepressant inhibition on morphine glucuronidation is low.PMID:38270153 | DOI:10.2174/0113892002270594231212090958 (Source: Current Drug Metabolism)
Source: Current Drug Metabolism - January 25, 2024 Category: Drugs & Pharmacology Authors: Verawan Uchaipichat Source Type: research

Inhibitory Effects of Tricyclic Antidepressants on Human Liver Microsomal Morphine Glucuronidation: Application of IVIVE to Predict Potential Drug-Drug Interactions in Humans
CONCLUSION: The results suggest that the likelihood of potential clinical DDIs arising from tricyclic antidepressant inhibition on morphine glucuronidation is low.PMID:38270153 | DOI:10.2174/0113892002270594231212090958 (Source: Current Drug Metabolism)
Source: Current Drug Metabolism - January 25, 2024 Category: Drugs & Pharmacology Authors: Verawan Uchaipichat Source Type: research

Inhibitory Effects of Tricyclic Antidepressants on Human Liver Microsomal Morphine Glucuronidation: Application of IVIVE to Predict Potential Drug-Drug Interactions in Humans
CONCLUSION: The results suggest that the likelihood of potential clinical DDIs arising from tricyclic antidepressant inhibition on morphine glucuronidation is low.PMID:38270153 | DOI:10.2174/0113892002270594231212090958 (Source: Current Drug Metabolism)
Source: Current Drug Metabolism - January 25, 2024 Category: Drugs & Pharmacology Authors: Verawan Uchaipichat Source Type: research

Inhibitory Effects of Tricyclic Antidepressants on Human Liver Microsomal Morphine Glucuronidation: Application of IVIVE to Predict Potential Drug-Drug Interactions in Humans
CONCLUSION: The results suggest that the likelihood of potential clinical DDIs arising from tricyclic antidepressant inhibition on morphine glucuronidation is low.PMID:38270153 | DOI:10.2174/0113892002270594231212090958 (Source: Current Drug Metabolism)
Source: Current Drug Metabolism - January 25, 2024 Category: Drugs & Pharmacology Authors: Verawan Uchaipichat Source Type: research

Low-Dose Naltrexone Improves post-COVID-19 condition Symptoms
Clin Ther. 2024 Jan 23:S0149-2918(24)00003-1. doi: 10.1016/j.clinthera.2023.12.009. Online ahead of print.ABSTRACTPURPOSE: Treatments for myalgic encephalomyelitis and chronic fatigue syndrome can be adapted for post-COVID-19 condition. Our aim was to compare treatments in patients from our post-COVID-19 clinic.METHODS: We conducted a retrospective cohort study and included consecutive patients enrolled in our post-COVID-19 clinic. We included patients who received low-dose naltrexone, amitriptyline, duloxetine, and physical therapy, and evaluated improvements in fatigue, pain, dyspnea, and brain fog recorded in the electr...
Source: Clinical Therapeutics - January 24, 2024 Category: Drugs & Pharmacology Authors: Leonardo Tamariz Elizabeth Bast Nancy Klimas Ana Palacio Source Type: research

The Practice of Prescribing Antidepressants During Pregnancy and Breastfeeding Among Mental Health Practitioners in Tertiary Care Centers in Oman
CONCLUSIONS: There was inconsistency among mental health practitioners in making prescription decisions and in their prescribing patterns.PMID:38264515 | PMC:PMC10801695 | DOI:10.5001/omj.2023.123 (Source: Oman Medical Journal)
Source: Oman Medical Journal - January 24, 2024 Category: Middle East Health Authors: Salim Al Kasbi Yousif Obaid Samir Al Adawi Sanjay Jaju Source Type: research

Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study
ConclusionIn all subgroups, regardless of prior preventive treatment failure type, eptinezumab demonstrated greater reductions in MMDs and higher MRRs compared with placebo.Trial RegistrationClinicalTrials.gov (Identifier: NCT04418765). (Source: Neurology and Therapy)
Source: Neurology and Therapy - January 18, 2024 Category: Neurology Source Type: research

Amitriptyline induced rosacea-like rash
(Source: Neurological Sciences)
Source: Neurological Sciences - January 15, 2024 Category: Neurology Source Type: research

A naturalistic study on the effects of antidepressants (e. g. SSRI) and acetyl salicylic acid (ASA) on the self-rated perception of the psychotherapeutic process of inpatient psychosomatic treatment and its results: Could ASA be beneficial?
Discussion: Regarding process perception and therapy outcome, amitriptyline might have unfavorable effects at dose reductions, whereas COX-inhibition could be beneficial at higher dosages. Similar findings have already been described with regard to COX-inhibition in depression and schizophrenia.PMID:38214019 | DOI:10.13109/zptm.2023.69.4.369 (Source: Zeitschrift fur Psychosomatische Medizin und Psychotherapie)
Source: Zeitschrift fur Psychosomatische Medizin und Psychotherapie - January 12, 2024 Category: Psychiatry Authors: Marius Binneb öse Jan Schott Hannah Wallis Christian Kaiser Matthias Vogel Source Type: research

Adverse drug events associated with nortriptyline compared with paroxetine and alternative medications in an older adult population: a retrospective cohort study in Southern California
Conclusions Compared with therapeutic alternatives, nortriptyline was found to represent a lower risk for falls, fractures and syncope, versus comparator medications, except for a few instances that had equivalent risk. The risk for these adverse events from paroxetine was comparable to the alternative medications. (Source: BMJ Open)
Source: BMJ Open - December 28, 2023 Category: General Medicine Authors: George, M. M., Deamer, R. L., Do, D. Tags: Open access, Geriatric medicine Source Type: research

Amitriptyline for the management of IBS in primary care
Family practitioners commonly manage irritable bowel syndrome (IBS) with the use of dietary modifications, antispasmodics, laxatives, or anti-diarrheal drugs. If these first-line therapies fail to improve symptoms, neuromodulators such as amitriptyline are recommended as a second-line treatment. However, amitriptyline is infrequently prescribed for the management of IBS in primary care as its efficacy has not previously been studied in this setting. (Source: Gastroenterology)
Source: Gastroenterology - December 24, 2023 Category: Gastroenterology Authors: Mohamed G. Shiha, Imran Aziz Tags: Gastro Digest Source Type: research

Amitriptyline for the Management of Irritable Bowel Syndrome in Primary Care
Ford AC, Wright-Hughes A, Alderson SL, et  al. Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2023;402(10414):1773–1785. (Source: Gastroenterology)
Source: Gastroenterology - December 24, 2023 Category: Gastroenterology Authors: Mohamed G. Shiha, Imran Aziz Tags: Digest Source Type: research

Clinical effectiveness of pharmacological interventions for managing chronic migraine in adults: a systematic review and network meta-analysis
We present a network meta-analysis to determine the effectiveness and rank of preventive drugs for chronic migraine in adults.MethodsWe identified, reviewed, and extracted data from randomised controlled trials (RCTs) of preventive drugs for chronic migraine with at least 200 participants. Data were analysed using network meta-analysis.FindingsWe included 12 RCTs of six medications (Eptinezumab, Erenumab, Fremanezumab, Galcanezumab, Onabotulinumtoxin A, and Topiramate) compared to placebo or each other. All drugs effectively reduced monthly headache and migraine days compared with placebo. The most effective drug for month...
Source: The Journal of Headache and Pain - December 6, 2023 Category: Neurology Source Type: research

Exploring the impact of antibiotics, microplastics, nanoparticles, and pesticides on zebrafish gut microbiomes: Insights into composition, interactions, and health implications
Chemosphere. 2023 Dec 2:140867. doi: 10.1016/j.chemosphere.2023.140867. Online ahead of print.ABSTRACTThis reviewdu addresses the impact of various chemical entities like pesticides, antibiotics, nanoparticles and microplastic on gut microbiota of zebrafish. Gut microbiota plays a vital role in metabolic regulation in every organism. As majority of metabolic pathways coordinated by microbiota, small alterations associated with mild to serious outcomes. Because of their unstoppable usage in day-to-day life, the present-day research on gut microbiota is mostly comprising aforementioned chemicals. It is better to understand h...
Source: Chemosphere - December 4, 2023 Category: Chemistry Authors: Rajesh Pamanji T N Kumareshan Lakshmi Priya S Gisha Sivan Joseph Selvin Source Type: research